ALwattar, J.K.; Assi, M.A.; Nasser, S.; Rahal, M.; Mehanna, M.M.
Raloxifene-Loaded Lipid Nanovesicles: A Journey to Select the Optimal Nanocarrier Formulation Through Characterization and Cytotoxic Analysis. Biomedicines 2025, 13, 2056.
https://doi.org/10.3390/biomedicines13092056
AMA Style
ALwattar JK, Assi MA, Nasser S, Rahal M, Mehanna MM.
Raloxifene-Loaded Lipid Nanovesicles: A Journey to Select the Optimal Nanocarrier Formulation Through Characterization and Cytotoxic Analysis. Biomedicines. 2025; 13(9):2056.
https://doi.org/10.3390/biomedicines13092056
Chicago/Turabian Style
ALwattar, Jana K, Mohammad Ahmad Assi, Sahar Nasser, Mohamad Rahal, and Mohammed M. Mehanna.
2025. "Raloxifene-Loaded Lipid Nanovesicles: A Journey to Select the Optimal Nanocarrier Formulation Through Characterization and Cytotoxic Analysis" Biomedicines 13, no. 9: 2056.
https://doi.org/10.3390/biomedicines13092056
APA Style
ALwattar, J. K., Assi, M. A., Nasser, S., Rahal, M., & Mehanna, M. M.
(2025). Raloxifene-Loaded Lipid Nanovesicles: A Journey to Select the Optimal Nanocarrier Formulation Through Characterization and Cytotoxic Analysis. Biomedicines, 13(9), 2056.
https://doi.org/10.3390/biomedicines13092056